Page last updated: 2024-08-22

platinum and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin

platinum has been researched along with 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bernhardy, AJ; Capelletti, M; Choi, YE; Chowdhury, D; D'Andrea, AD; Harrell, MI; Johnson, N; Johnson, SF; Li, YC; Liu, JF; Miron, A; Moreau, LA; Sarosiek, KA; Shapiro, GI; Swisher, EM; Wang, Y; Wickramanayake, A; Yao, W	1

Other Studies

1 other study(ies) available for platinum and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin

Article	Year
Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. Proceedings of the National Academy of Sciences of the United States of America, 2013, Oct-15, Volume: 110, Issue:42 Topics: Antineoplastic Agents; Benzoquinones; BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Fanconi Anemia Complementation Group N Protein; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mutation; Nuclear Proteins; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Structure, Tertiary; Rad51 Recombinase; Tumor Suppressor Proteins	2013

Article

Year

Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance.

Proceedings of the National Academy of Sciences of the United States of America, 2013, Oct-15, Volume: 110, Issue:42

Topics: Antineoplastic Agents; Benzoquinones; BRCA1 Protein; BRCA2 Protein; Cell Line, Tumor; Cisplatin; Drug Resistance, Neoplasm; Fanconi Anemia Complementation Group N Protein; Female; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Mutation; Nuclear Proteins; Ovarian Neoplasms; Platinum; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Protein Structure, Tertiary; Rad51 Recombinase; Tumor Suppressor Proteins

2013